Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2021.
The company has reported a fall of 30.20% in its net profit at Rs 193.58 crore for the quarter under review as compared to Rs 277.35 crore for the same quarter in the previous year. Total income of the company decreased by 0.34% at Rs 1234.25 crore for Q3FY22 as compared Rs 1238.47 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 39.70% in its net profit at Rs 176.42 crore for the quarter under review as compared to Rs 292.57 crore for the same quarter in the previous year. Total income of the company decreased by 3.33% at Rs 1273.04 crore for Q3FY22 as compared Rs 1316.86 crore for the corresponding quarter previous year.
